Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

CASI Pharmaceuticals, Inc. CASI

Full chart Compare
Set alert

Price alert · CASI

All alert types
0.15 USD 0.00 (+0.00%)

Mar 17, 2026, 9:30 AM EDT

0.15 Day range 0.1505

52-week range unavailable

YTD
-82.29%
1 year
-92.24%

Financial health

Altman Z-Score

-47.98 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.1×
FY 2015: -4.3×FY 2016: -6.8×FY 2017: -18.6×FY 2018: -12.4×FY 2019: -6.4×FY 2020: -6.8×FY 2021: -3.0×FY 2022: -0.6×FY 2023: -3.5×FY 2024: -1.1×
FY 2015 5y median -3.0× FY 2024
P/S 1.5×
FY 2015: 653×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 71.8×FY 2020: 21.5×FY 2021: 3.6×FY 2022: 0.6×FY 2023: 2.8×FY 2024: 1.5×
FY 2015 5y median 2.8× FY 2024
P/B 23.5×
FY 2015: -5.1×FY 2016: 3.1×FY 2017: 5.2×FY 2018: 3.1×FY 2019: 4.1×FY 2020: 4.0×FY 2021: 1.3×FY 2022: 0.5×FY 2023: 4.0×FY 2024: 23.5×
FY 2015 5y median 4.0× FY 2024
P/FCF -1.5×
FY 2015: -5.6×FY 2016: -10.3×FY 2017: -27.2×FY 2018: -6.8×FY 2019: -8.0×FY 2020: -7.2×FY 2021: -2.6×FY 2022: -0.9×FY 2023: -4.3×FY 2024: -1.5×
FY 2015 5y median -2.6× FY 2024
EV/EBITDA -1.5×
FY 2015: -3.9×FY 2016: -4.1×FY 2017: -14.8×FY 2018: -10.0×FY 2019: -6.5×FY 2020: -8.7×FY 2021: -2.2×FY 2022: 0.6×FY 2023: -4.6×FY 2024: -1.5×
FY 2015 5y median -2.2× FY 2024
EV/Sales 1.8×
FY 2015: 576×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 59.3×FY 2020: 18.0×FY 2021: 2.5×FY 2022: -0.5×FY 2023: 2.9×FY 2024: 1.8×
FY 2015 5y median 2.5× FY 2024
FCF Yield -67.9%
FY 2015: -17.8%FY 2016: -9.7%FY 2017: -3.7%FY 2018: -14.8%FY 2019: -12.6%FY 2020: -13.9%FY 2021: -38.9%FY 2022: -109.3%FY 2023: -23.2%FY 2024: -67.9%
FY 2015 5y median -38.9% FY 2024

Profitability

Gross Margin 39.1%
FY 2015: 86.9%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 4.7%FY 2020: 37.2%FY 2021: 58.4%FY 2022: 63.3%FY 2023: 59.2%FY 2024: 39.1%
FY 2015 5y median 58.4% FY 2024
Operating Margin -138.8%
FY 2015: 14990.8%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -968.1%FY 2020: -348.6%FY 2021: -137.6%FY 2022: -61.5%FY 2023: -74.0%FY 2024: -138.8%
FY 2015 5y median -137.6% FY 2024
Net Margin -137.6%
FY 2015: -15104.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -1098.1%FY 2020: -318.9%FY 2021: -121.5%FY 2022: -95.1%FY 2023: -79.5%FY 2024: -137.6%
FY 2015 5y median -121.5% FY 2024
ROE -2120.9%
FY 2015: 118.4%FY 2016: -45.5%FY 2017: -27.9%FY 2018: -25.1%FY 2019: -62.1%FY 2020: -59.2%FY 2021: -43.4%FY 2022: -92.0%FY 2023: -111.5%FY 2024: -2120.9%
FY 2015 5y median -92.0% FY 2024
ROIC -108.2%
FY 2015: 149.9%FY 2016: 35.7%FY 2017: -26.9%FY 2018: -23.9%FY 2019: -41.7%FY 2020: -43.3%FY 2021: -32.3%FY 2022: -33.1%FY 2023: -42.2%FY 2024: -108.2%
FY 2015 5y median -42.2% FY 2024
ROA -73.1%
FY 2015: -123.7%FY 2016: -34.1%FY 2017: -23.9%FY 2018: -24.2%FY 2019: -44.2%FY 2020: -37.8%FY 2021: -26.5%FY 2022: -42.6%FY 2023: -35.8%FY 2024: -73.1%
FY 2015 5y median -37.8% FY 2024

Growth (YoY)

Revenue -15.8%
FY 2015: 101.1%FY 2016: -100.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 266.5%FY 2021: 99.2%FY 2022: 42.9%FY 2023: -21.4%FY 2024: -15.8%
FY 2015 FY 2024
Operating Income -58.0%
FY 2015: -72.7%FY 2016: 31.7%FY 2017: -214.1%FY 2018: -146.5%FY 2019: -50.9%FY 2020: -32.0%FY 2021: 21.3%FY 2022: 36.2%FY 2023: 5.3%FY 2024: -58.0%
FY 2015 FY 2024
EPS (diluted) -26.7%
FY 2015: 75.8%FY 2016: 23.9%FY 2017: -3.6%FY 2018: -85.1%FY 2019: -48.1%FY 2020: 9.0%FY 2021: 38.4%FY 2022: -11.9%FY 2023: 32.9%FY 2024: -26.7%
FY 2015 FY 2024
Free Cash Flow -32.7%
FY 2015: -24.1%FY 2016: -12.8%FY 2017: -17.5%FY 2018: -586.4%FY 2019: 26.0%FY 2020: -21.3%FY 2021: 6.3%FY 2022: 36.9%FY 2023: 16.8%FY 2024: -32.7%
FY 2015 FY 2024

Financial Health

Current Ratio 1.1×
FY 2015: 5.3×FY 2016: 20.9×FY 2017: 8.7×FY 2018: 23.9×FY 2019: 7.7×FY 2020: 9.3×FY 2021: 4.7×FY 2022: 4.3×FY 2023: 3.5×FY 2024: 1.1×
FY 2015 5y median 4.3× FY 2024
Quick Ratio 0.9×
FY 2015: 5.3×FY 2016: 20.9×FY 2017: 8.7×FY 2018: 23.8×FY 2019: 7.2×FY 2020: 9.1×FY 2021: 4.6×FY 2022: 4.0×FY 2023: 2.6×FY 2024: 0.9×
FY 2015 5y median 4.0× FY 2024
Debt / Equity 12.0×
FY 2015: -0.2×FY 2016: 0.1×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.0×FY 2023: 0.9×FY 2024: 12.0×
FY 2015 5y median 0.1× FY 2024
Net Debt / EBITDA -0.2×
FY 2015: 0.5×FY 2016: 2.7×FY 2017: 3.9×FY 2018: 3.2×FY 2019: 1.4×FY 2020: 1.7×FY 2021: 1.0×FY 2022: 1.3×FY 2023: -0.2×FY 2024: -0.2×
FY 2015 5y median 1.0× FY 2024
Interest Coverage -45.5×
FY 2015: 86.7×FY 2016: 279×FY 2017: -718×FY 2018: -3229×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -427×FY 2023: 0.0×FY 2024: -45.5×
FY 2015 5y median 0.0× FY 2024

Dividends

Dividend Yield 1.7%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.8%FY 2024: 1.7%
FY 2015 5y median 0.0% FY 2024
Payout Ratio -1.8%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -2.7%FY 2024: -1.8%
FY 2015 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31